Loading...
01/11 17:07
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate strong revenue growth, record high revenue, and optimistic guidance, which are positive indicators. The company has announced a new market entry in India, new client wins, and a share repurchase program, all of which are favorable. Despite some margin decline due to strategic investments, the overall sentiment remains positive, especially with the raised guidance and strategic growth initiatives. The stock price is likely to react positively in the short term.
Revenue $140.7 million, up 11% from $126.8 million in the prior year quarter. Growth driven by HealthTech (20%), Travel, Transportation and Logistics (19%), and Retail & E-commerce (15%), partially offset by a decline in FinTech (12%).
Adjusted EBITDA $19.4 million, or 13.8% of revenue, compared to $19.2 million, or 15.1% of revenue in the prior year. The decline in margin was due to increased selling, general and administrative expenses related to investments in India and technology.
Net Income $10.5 million, up from $10.3 million in the prior year quarter. Growth driven by increased work in higher-margin offshore regions (19% year-over-year) and cost optimization efforts, offset by higher selling, general and administrative expenses.
Adjusted EPS $0.82, up 18% from $0.70 in the prior year quarter. Growth driven by higher revenue, improved operating performance, and fewer diluted shares outstanding.
Free Cash Flow $3.6 million, down from $9.7 million in the prior year quarter. The decrease was due to increased capital expenditures and investments in organizational teams and technology.
Capital Expenditures $5.3 million, or 3.7% of revenue, compared to $1.7 million, or 1.3% of revenue in the prior year quarter. The increase was driven by expansion to meet demand in offshore and near-shore regions.
Net Debt $7.6 million, improved from $13.7 million at the end of the second quarter. Improvement due to the retirement of a $25 million convertible note.
Wave iX AI solutions: In the quarter, we had great success with our market-leading Wave iX AI solutions, winning and launching several clients with our AI Automate and AI Translate offerings.
Entry into India market: We achieved a major strategic milestone in the quarter with our entry into the India market for a leading health care client.
Organic revenue growth: We have returned to double-digit organic revenue growth at 11%, marking our best growth in more than 2 years.
Adjusted EBITDA: We delivered adjusted EBITDA of $19.4 million at a margin of 13.8%.
Gross margin improvement: We expanded gross margin by 50 basis points.
New share repurchase program: We are launching a new $15 million share repurchase program.
Raised full-year guidance: We are raising full-year guidance on both revenue and EBITDA.
Competitive Pressures: IBEX faces competitive pressures from larger competitors, particularly in securing new logo opportunities. Despite this, the company has successfully won significant contracts against these competitors.
Regulatory Issues: The company has noted that U.S. trade tariffs do not directly impact their business, as their services fall outside the scope of these measures. However, there is a potential indirect impact on client volumes, which is currently believed to be limited.
Supply Chain Challenges: No specific supply chain challenges were mentioned, but the company is expanding into new markets, which may introduce complexities.
Economic Factors: The company has seen a decline in the FinTech vertical, attributed to changes in client payment support models and geographic shifts from onshore to offshore delivery.
Investment Risks: IBEX is making significant investments in technology and expansion into the Indian market, which could pose risks if these investments do not yield expected returns.
New Market Entry: IBEX has entered the India market for a leading health care client, which is a strategic priority for the company.
Client Acquisition: IBEX won 4 key new logo opportunities in Q3 FY 2025, totaling 12 for the year, including a significant win with a top-tier global e-commerce company.
AI Solutions: IBEX launched several clients with its Wave iX AI solutions, enhancing client stickiness and competitive advantage.
Growth Strategy: The company is focused on a land and expand strategy with existing clients, particularly in high-margin offshore regions.
Revenue Guidance: For fiscal year 2025, revenue is now expected to be in the range of $540 million to $545 million, up from a previous range of $525 million to $535 million.
EBITDA Guidance: Adjusted EBITDA is expected to be in the range of $68 million to $70 million, revised from the previous range of $68 million to $69 million.
Capital Expenditures: Capital expenditures are expected to remain in the range of $15 million.
Share Repurchase Program: IBEX announced a new $15 million share repurchase program.
Share Repurchase Details: The company completed the repayment of the seller financing note to TRGI associated with the strategic repurchase of approximately 3.6 million shares.
The earnings call summary indicates strong financial performance with a 16.5% revenue increase and a 74.1% rise in adjusted EPS. The guidance was raised, and share repurchases were made, both positive indicators. Despite some risks like a decline in telecommunications and increased CapEx, the growth in other verticals and AI investments are promising. The Q&A session confirmed management's confidence in future growth. Overall, the sentiment is positive, suggesting a stock price increase of 2% to 8% over the next two weeks.
The earnings call reflects strong financial performance with record-high revenue and EPS growth, positive guidance, and successful market expansion, particularly in India. The Q&A session confirms sustainable growth in key areas and a positive outlook on AI integration. Despite increased expenses, the share repurchase plan supports shareholder value. Overall, the positive financials and strategic moves outweigh the risks, suggesting a positive stock price movement.
The earnings call summary and Q&A indicate strong revenue growth, record high revenue, and optimistic guidance, which are positive indicators. The company has announced a new market entry in India, new client wins, and a share repurchase program, all of which are favorable. Despite some margin decline due to strategic investments, the overall sentiment remains positive, especially with the raised guidance and strategic growth initiatives. The stock price is likely to react positively in the short term.
IBEX reported record revenue growth and improved margins, with optimistic guidance for FY 2025. The company announced a successful share repurchase program, a positive signal for shareholder returns. Despite some risks like competitive pressures and economic factors, the overall sentiment is positive, supported by strong financial performance and strategic client diversification. The Q&A section revealed stable demand and continued market share gains, reinforcing the positive outlook. The stock price is expected to rise by 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
